These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 503921)

  • 1. [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer].
    Stadnicki A
    Pol Tyg Lek; 1979 Jun; 34(26):1029-31. PubMed ID: 503921
    [No Abstract]   [Full Text] [Related]  

  • 2. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients.
    Loginov AS; Speransky MD; Speranskaya IE; Vasilyev UV; Alecseev VF
    Scand J Gastroenterol Suppl; 1980; 65():85-91. PubMed ID: 7010530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peptic ulcer with Biogastrone (carbenoxolone)].
    Brailski Kh; Dimitrov B
    Vutr Boles; 1979; 18(5):37-44. PubMed ID: 516651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind study of proglumide, zolimidine and carbenoxolone in peptic ulcer and gastroduodenitis].
    Corazza GR; D'Ambro A; Grimoldi D
    Minerva Dietol Gastroenterol; 1979; 25(1):47-58. PubMed ID: 156316
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled clinical evaluation of the therapeutic activity of 3 antiulcer agents in peptic ulcer: carbenoxolone, proglumide and zolimidine].
    Fossati C
    Clin Ter; 1979 Mar; 88(6):605-19. PubMed ID: 157245
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum carbenoxolone: ulcer-healing and metabolic effects.
    Wright PA; Reed PI; Davies WA; St John DJ; Young GP; House FR; Gribble RJ; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():41-8. PubMed ID: 6937940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs for peptic ulcer.
    Jones FA; Hunt T
    World J Surg; 1979 Sep; 3(5):659-60. PubMed ID: 516781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Peptic ulcer: a social and therapeutic problem still current].
    Visconti GP; Spotti D; Vigorelli PE; Geniram A
    Recenti Prog Med; 1979 Nov; 67(5):530-45. PubMed ID: 42955
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controlled clinical study of the effectiveness of a new anti-ulcer drug: thiopropamine].
    Masoero G
    Clin Ter; 1979 Aug; 90(3):261-72. PubMed ID: 399873
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of peptic ulcer in the stomach and duodenum using carbenoxolone (Biogastrone and Biogastrone-Duodenal)].
    Ronský R; Fric P; Huslarová A; Malis F; Josífko M
    Cesk Gastroenterol Vyz; 1978 Mar; 32(2):98-104. PubMed ID: 350435
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium.
    Guslandi M
    Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation.
    Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
    Eur J Clin Invest; 1983 Aug; 13(4):351-6. PubMed ID: 6413222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial.
    Reed PI; Lewis SI; Vincent-Brown A; Holdstock DJ; Gribble RJ; Murgatroyd RE; Baron JH
    Scand J Gastroenterol Suppl; 1980; 65():51-7. PubMed ID: 7010528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histochemistry of the gastric and duodenal mucosa under cimetidine and carbenoxolone treatment.
    Lojda Z; Maratka Z
    Scand J Gastroenterol Suppl; 1989; 167():13-5. PubMed ID: 2617161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on the effects of carbenozolone and trimipramine on peptic ulcer healing.
    Myren J; Berstad A
    Scand J Gastroenterol Suppl; 1976; 42():159-61. PubMed ID: 796969
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of carbenoxolone and cimetidine in the management of duodenal ulcer.
    Reed PI; Vincent-Brown A; Cook PJ; Colaco CB; Perks S; Baron JH; Jewell DP
    Acta Gastroenterol Belg; 1983; 46(9-10):459-68. PubMed ID: 6673457
    [No Abstract]   [Full Text] [Related]  

  • 19. [Undesirable effects of Biogastrone in the treatment of peptic ulcer (author's transl)].
    Zelenková J; Toman R; Svoboda M; Svihovec J
    Cesk Gastroenterol Vyz; 1976 Oct; 30(7):427-33. PubMed ID: 797473
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
    Parodi MC; Molinari F; Barocci S
    Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.